Skip to main content
Erschienen in: Neuroradiology 6/2008

01.06.2008 | Functional Neuroradiology

Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI

verfasst von: Mohammad Haris, Rakesh Kumar Gupta, Anup Singh, Nuzhat Husain, Mazhar Husain, Chandra Mohan Pandey, Chhitij Srivastava, Sanjay Behari, Ram Kishore Singh Rathore

Erschienen in: Neuroradiology | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

It is not always possible to differentiate infective from neoplastic brain lesions with conventional MR imaging. In this study, we assessed the utility of various perfusion indices in the differentiation of infective from neoplastic brain lesions.

Methods

A total of 103 patients with infective brain lesions (group I, n=26) and neoplastic brain lesions (high-grade glioma, HGG, group II, n=52; low-grade glioma, LGG, group III, n=25) underwent dynamic contrast-enhanced MR imaging. The perfusion indices, including relative cerebral blood volume (rCBV), relative cerebral blood flow (rCBF), transfer coefficient (ktrans) and leakage (ve), were calculated and their degree of correlation with immunohistologically obtained microvessel density (MVD) and vascular endothelial growth factor (VEGF) determined. The rCBV was corrected for the leakage effect. Discriminant analysis for rCBV, rCBF, ktrans and ve was performed to predict the group membership of each case and post hoc analysis was performed to look for group differences.

Results

The rCBV, rCBF, ktrans, ve, MVD and VEGF were significantly different (P<0.001) between the three groups. Discriminant analysis showed that rCBV predicted 73.1% of the infective lesions, 84.6% of the HGG and 72.0% of the LGG. The rCBF classified 86.5% of the HGG, 80.0% of the LGG and 65.4% of the infective lesions. The ktrans discriminated 98.1% of the HGG, 76.0% of the LGG and 88.5% of the infective lesions correctly. The ve classified 98.1% of the HGG, 76.0% of the LGG and 84.6% the infective lesions. The rCBV was correlated significantly with MVD and VEGF, while the correlation between ktrans and MVD was not significant.

Conclusion

Physiological perfusion indices such as ktrans and ve appear to be useful in differentiating infective from neoplastic brain lesions. Adding these indices to the current imaging protocol is likely to improve tissue characterization of these focal brain mass lesions.
Literatur
1.
Zurück zum Zitat Gupta RK, Kathuria M, Pradhan S (1999) Magnetization transfer MR imaging in CNS tuberculosis. AJNR Am J Neuroradiol 20:867–875PubMed Gupta RK, Kathuria M, Pradhan S (1999) Magnetization transfer MR imaging in CNS tuberculosis. AJNR Am J Neuroradiol 20:867–875PubMed
2.
Zurück zum Zitat Gupta RK, Husain M, Vatsal DK, Kumar R, Chawla S, Husain N (2002) Comparative evaluation of magnetization transfer MR imaging and in-vivo proton MR spectroscopy in brain tuberculomas. Magn Reson Imaging 20:375–381PubMedCrossRef Gupta RK, Husain M, Vatsal DK, Kumar R, Chawla S, Husain N (2002) Comparative evaluation of magnetization transfer MR imaging and in-vivo proton MR spectroscopy in brain tuberculomas. Magn Reson Imaging 20:375–381PubMedCrossRef
3.
Zurück zum Zitat Mishra AM, Gupta RK, Jaggi RS, Reddy JS, Jha DK, Husain N, Prasad KN, Behari S, Husain M (2004) Role of diffusion-weighted imaging and in vivo proton MR spectroscopy in the differential diagnosis of ring enhancing intracranial cystic mass lesions. J Comput Assist Tomogr 28:540–547PubMedCrossRef Mishra AM, Gupta RK, Jaggi RS, Reddy JS, Jha DK, Husain N, Prasad KN, Behari S, Husain M (2004) Role of diffusion-weighted imaging and in vivo proton MR spectroscopy in the differential diagnosis of ring enhancing intracranial cystic mass lesions. J Comput Assist Tomogr 28:540–547PubMedCrossRef
4.
Zurück zum Zitat Garg M, Gupta RK, Husain M, Chawla S, Chawla J, Kumar R, Rao SB, Misra MK, Prasad KN (2004) Brain abscesses: etiologic categorization with in vivo proton MR spectroscopy. Radiology 230:519–527PubMedCrossRef Garg M, Gupta RK, Husain M, Chawla S, Chawla J, Kumar R, Rao SB, Misra MK, Prasad KN (2004) Brain abscesses: etiologic categorization with in vivo proton MR spectroscopy. Radiology 230:519–527PubMedCrossRef
5.
Zurück zum Zitat Holmes TM, Petrella JR, Provenzale JM (2004) Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI. AJNR Am J Neuroradiol 183:1247–1252 Holmes TM, Petrella JR, Provenzale JM (2004) Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI. AJNR Am J Neuroradiol 183:1247–1252
6.
Zurück zum Zitat Chan JH, Tsui EY, Chau LF, Chow KY, Chan MS, Yuen MK, Chan TL, Cheng WK, Wong KP (2002) Discrimination of an infected brain tumor by cerebral brain abscess by combined MR perfusion and diffusion imaging. Comput Med Imaging Graph 26:19–23PubMedCrossRef Chan JH, Tsui EY, Chau LF, Chow KY, Chan MS, Yuen MK, Chan TL, Cheng WK, Wong KP (2002) Discrimination of an infected brain tumor by cerebral brain abscess by combined MR perfusion and diffusion imaging. Comput Med Imaging Graph 26:19–23PubMedCrossRef
7.
Zurück zum Zitat Batra A, Tripathi RP (2003) Perfusion magnetic resonance imaging in intracerebral parenchymal tuberculosis: preliminary findings. J Comput Assist Tomogr 27:882–888PubMedCrossRef Batra A, Tripathi RP (2003) Perfusion magnetic resonance imaging in intracerebral parenchymal tuberculosis: preliminary findings. J Comput Assist Tomogr 27:882–888PubMedCrossRef
8.
Zurück zum Zitat Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29:15–18PubMed Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29:15–18PubMed
9.
10.
Zurück zum Zitat Machein MR, Kullmer J, Fiebich BL, Plate KH, Wamke PC (1999) Vascular endothelial growth factor expression, vascular volume, and capillary permeability in human brain tumors. Neurosurgery 44:732–741PubMedCrossRef Machein MR, Kullmer J, Fiebich BL, Plate KH, Wamke PC (1999) Vascular endothelial growth factor expression, vascular volume, and capillary permeability in human brain tumors. Neurosurgery 44:732–741PubMedCrossRef
11.
Zurück zum Zitat van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M, Kolk AH, Springer P, Hoepelman AI, Kimpen JL, Schoeman JF (2004) Vascular endothelial growth factor and blood brain barrier disruption in tuberculous meningitis. Pediatr Infect Dis J 23:608–613PubMedCrossRef van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M, Kolk AH, Springer P, Hoepelman AI, Kimpen JL, Schoeman JF (2004) Vascular endothelial growth factor and blood brain barrier disruption in tuberculous meningitis. Pediatr Infect Dis J 23:608–613PubMedCrossRef
12.
Zurück zum Zitat Abe Y, Sugisaki K, Dannenberg AM Jr (1996) Rabbit vascular endothelial adhesion molecules: ELAM-1 is most elevated in acute inflammation, whereas VCAM-1 and ICAM-1 predominate in chronic inflammation. J Leukoc Biol 60:692–703PubMed Abe Y, Sugisaki K, Dannenberg AM Jr (1996) Rabbit vascular endothelial adhesion molecules: ELAM-1 is most elevated in acute inflammation, whereas VCAM-1 and ICAM-1 predominate in chronic inflammation. J Leukoc Biol 60:692–703PubMed
13.
Zurück zum Zitat Kielian T, Hickey WF (2000) Proinflammatory cytokine, chemokine, and cellular adhesion molecule expression during the acute phase of experimental brain abscess development. Am J Pathol 157:647–658PubMed Kielian T, Hickey WF (2000) Proinflammatory cytokine, chemokine, and cellular adhesion molecule expression during the acute phase of experimental brain abscess development. Am J Pathol 157:647–658PubMed
14.
Zurück zum Zitat Baldwin AC, Kielian T (2004) Persistent immune activation associated with a mouse model of Staphylococcus aureus-induced experimental brain abscess. J Neuroimmunol 151:24–32PubMedCrossRef Baldwin AC, Kielian T (2004) Persistent immune activation associated with a mouse model of Staphylococcus aureus-induced experimental brain abscess. J Neuroimmunol 151:24–32PubMedCrossRef
15.
Zurück zum Zitat Jackson A (2003) Imaging microvasculature structure with contrast enhanced MRI. Br J Radiol 76:159–173CrossRef Jackson A (2003) Imaging microvasculature structure with contrast enhanced MRI. Br J Radiol 76:159–173CrossRef
16.
Zurück zum Zitat Cha S, Lu S, Johnson G, Knopp EA (2000) Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging 11:114–119PubMedCrossRef Cha S, Lu S, Johnson G, Knopp EA (2000) Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging 11:114–119PubMedCrossRef
17.
Zurück zum Zitat Aronen HJ, Glass J, Pardo FS, Belliveau JW, Gruber ML, Buchbinder BR, Gazit IE, Linggood RM, Fischman AJ, Rosen BR (1995) Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol 36:520–528PubMedCrossRef Aronen HJ, Glass J, Pardo FS, Belliveau JW, Gruber ML, Buchbinder BR, Gazit IE, Linggood RM, Fischman AJ, Rosen BR (1995) Echo-planar MR cerebral blood volume mapping of gliomas: clinical utility. Acta Radiol 36:520–528PubMedCrossRef
18.
Zurück zum Zitat Aronen HJ, Perkio J (2002) Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin N Am 12:501–523PubMedCrossRef Aronen HJ, Perkio J (2002) Dynamic susceptibility contrast MRI of gliomas. Neuroimaging Clin N Am 12:501–523PubMedCrossRef
19.
Zurück zum Zitat Jackson A (2004) Analysis of dynamic contrast enhanced MRI. Br J Radiol 77:154–166CrossRef Jackson A (2004) Analysis of dynamic contrast enhanced MRI. Br J Radiol 77:154–166CrossRef
20.
Zurück zum Zitat Singh A, Haris M, Rathore D, Purwar A, Sarma MK, Bayu G, Husain N, Rathore RK, Gupta RK (2007) Quantification of physiological and hemodynamic indices using T1 dynamic contrast-enhanced MRI in intracranial mass lesions. J Magn Reson Imaging 26:871–880PubMedCrossRef Singh A, Haris M, Rathore D, Purwar A, Sarma MK, Bayu G, Husain N, Rathore RK, Gupta RK (2007) Quantification of physiological and hemodynamic indices using T1 dynamic contrast-enhanced MRI in intracranial mass lesions. J Magn Reson Imaging 26:871–880PubMedCrossRef
21.
Zurück zum Zitat Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225PubMed Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225PubMed
22.
Zurück zum Zitat Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC (1998) Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22:139–152PubMedCrossRef Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC (1998) Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22:139–152PubMedCrossRef
23.
Zurück zum Zitat Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039PubMed Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039PubMed
24.
Zurück zum Zitat Shweiki D, Neerman M, Itin A, Keshet E (1995) Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A 92:768–772PubMedCrossRef Shweiki D, Neerman M, Itin A, Keshet E (1995) Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci U S A 92:768–772PubMedCrossRef
25.
Zurück zum Zitat Black KL, Ningaraj NS (2004) Modulation of tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control 11:165–173PubMed Black KL, Ningaraj NS (2004) Modulation of tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control 11:165–173PubMed
26.
Zurück zum Zitat Chio CC, Baba T, Black KL (1992) Selective blood-tumor barrier disruption by leukotrienes. J Neurosurg 77:407–410PubMedCrossRef Chio CC, Baba T, Black KL (1992) Selective blood-tumor barrier disruption by leukotrienes. J Neurosurg 77:407–410PubMedCrossRef
27.
Zurück zum Zitat Uchida M, Chen Z, Liu Y, Black KL (2002) Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase. Neurol Res 24:739–774PubMedCrossRef Uchida M, Chen Z, Liu Y, Black KL (2002) Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase. Neurol Res 24:739–774PubMedCrossRef
28.
Zurück zum Zitat Premack BA, Schall TJ (1996) Chemokine receptors: gateways to inflammation and infection. Nat Med 2:1174–1178PubMedCrossRef Premack BA, Schall TJ (1996) Chemokine receptors: gateways to inflammation and infection. Nat Med 2:1174–1178PubMedCrossRef
29.
Zurück zum Zitat Maenpaa A, Kovanen PE, Paetau A, Jaaskelainen J, Timonen T (1997) Lymphocyte adhesion molecule ligands and extracellular matrix proteins in gliomas and normal brain: expression of VCAM-1 in gliomas. Acta Neuropathol 94:216–225PubMedCrossRef Maenpaa A, Kovanen PE, Paetau A, Jaaskelainen J, Timonen T (1997) Lymphocyte adhesion molecule ligands and extracellular matrix proteins in gliomas and normal brain: expression of VCAM-1 in gliomas. Acta Neuropathol 94:216–225PubMedCrossRef
30.
Zurück zum Zitat Badruddoja MA, Krouwer HG, Rand SD, Rebro KJ, Pathak AP, Schmainda KM (2003) Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neuro Oncol 5:235–243PubMedCrossRef Badruddoja MA, Krouwer HG, Rand SD, Rebro KJ, Pathak AP, Schmainda KM (2003) Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neuro Oncol 5:235–243PubMedCrossRef
31.
Zurück zum Zitat Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, Johnson G (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746–755PubMed Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, Johnson G (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746–755PubMed
32.
Zurück zum Zitat Patankar TF, Haroon HA, Mills SJ, Baleriaux D, Bukley DL, Parker GJ (2005) Is volume transfer coefficient (ktrans) related to histologic grade in human gliomas. AJNR Am J Neuroradiol 26:2455–2465PubMed Patankar TF, Haroon HA, Mills SJ, Baleriaux D, Bukley DL, Parker GJ (2005) Is volume transfer coefficient (ktrans) related to histologic grade in human gliomas. AJNR Am J Neuroradiol 26:2455–2465PubMed
33.
Zurück zum Zitat Roberts HC, Roberts TP, Brasch RC, Dillon WP (2000) Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 21:891–899PubMed Roberts HC, Roberts TP, Brasch RC, Dillon WP (2000) Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 21:891–899PubMed
Metadaten
Titel
Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI
verfasst von
Mohammad Haris
Rakesh Kumar Gupta
Anup Singh
Nuzhat Husain
Mazhar Husain
Chandra Mohan Pandey
Chhitij Srivastava
Sanjay Behari
Ram Kishore Singh Rathore
Publikationsdatum
01.06.2008
Verlag
Springer-Verlag
Erschienen in
Neuroradiology / Ausgabe 6/2008
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-008-0378-6

Weitere Artikel der Ausgabe 6/2008

Neuroradiology 6/2008 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.